Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 2/20 | 0.71 |
| ▸ | CASP2 | P42575 | 1/20 | 0.60 |
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.55 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.49 |
| ▸ | ZDHHC2 | Q9UIJ5 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1960248 | 1.00 | MCL1 (0.71) | MCL1CASP2NAAAEPHX1FAAH | |
| SCHEMBL1962966 | 1.00 | MCL1 (0.71) | MCL1CASP2NAAAEPHX1FAAH | |
| SCHEMBL1958608 | 1.00 | MCL1 (0.71) | MCL1CASP2NAAAEPHX1FAAH | |
| SCHEMBL6320829 | 1.00 | MCL1 (0.71) | MCL1CASP2NAAAEPHX1FAAH | |
| SCHEMBL1962363 | 1.00 | MCL1 (0.71) | MCL1CASP2NAAAEPHX1FAAH | |
| SCHEMBL1961150 | 1.00 | MCL1 (0.71) | MCL1CASP2NAAAEPHX1FAAH | |
| SCHEMBL3394896 | 1.00 | MCL1 (0.71) | MCL1CASP2NAAAEPHX1FAAH | |
| SCHEMBL1961539 | 1.00 | MCL1 (0.71) | MCL1CASP2NAAAEPHX1FAAH | |
| SCHEMBL1962964 | 1.00 | MCL1 (0.71) | MCL1CASP2NAAAEPHX1FAAH | |
| SCHEMBL1958356 | 1.00 | MCL1 (0.71) | MCL1CASP2NAAAEPHX1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9976103-B2 | Lubricating composition containing an antiwear agent | THE LUBRIZOL CORPORATION (US) | 2018-05-22 | — | — | US | disclosed |
| EP-2513269-B1 | LUBRICATING COMPOSITION CONTAINING AN ANTIWEAR AGENT | LUBRIZOL CORP (US) | 2017-10-25 | — | — | EP | disclosed |
| US-9708563-B2 | Lubricating composition containing an antiwear agent | THE LUBRIZOL CORPORATION (US) | 2017-07-18 | — | — | US | disclosed |
| US-20150267140-A1 | LUBRICATING COMPOSITION CONTAINING AN ANTIWEAR AGENT | LUBRIZOL CORP (US) | 2015-09-24 | — | — | US | disclosed |
| US-20130172221-A1 | Lubricating Composition Containing an Antiwear Agent | THE LUBRIZOL CORPORATION (US) | 2013-07-04 | — | — | US | disclosed |
| US-20120309657-A1 | Lubricating Composition Containing an Antiwear Agent | THE LUBRIZOL CORPORATION (US) | 2012-12-06 | — | — | US | disclosed |
| EP-2513272-A1 | LUBRICATING COMPOSITION CONTAINING AN ANTIWEAR AGENT | The Lubrizol Corporation (US) | 2012-10-24 | — | — | EP | disclosed |
| EP-2513269-A1 | LUBRICATING COMPOSITION CONTAINING AN ANTIWEAR AGENT | The Lubrizol Corporation (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011081835-A1 | LUBRICATING COMPOSITION CONTAINING AN ANTIWEAR AGENT | THE LUBRIZOL CORPORATION (US) | 2011-07-07 | — | — | WO | disclosed |
| WO-2011075403-A1 | LUBRICATING COMPOSITION CONTAINING AN ANTIWEAR AGENT | THE LUBRIZOL CORPORATION (US) | 2011-06-23 | — | — | WO | disclosed |
| US-20040254241-A1 | Enzyme inhibitor; cognition activators | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| EP-1431280-A1 | ARYL SULFAMATE DERIVATIVES | Kyowa Hakko Kogyo Co., Ltd (JP) | 2004-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254241-A1 | Enzyme inhibitor; cognition activators | SULT1A1, STS, CYP26A1 | MCL1 4226/4885CASP2 2385/4885NAAA 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.